Program

In-person AND virtual! – We are pioneering a new conference format that will connect in-person and virtual audiences to create a unique experience. Matching the innovation that comes through our members’ work, ISPOR is pushing the boundaries of innovation to design an event that works in today’s quickly changing environment. 

In-person registration included the full virtual experience, and virtual-only attendees will be able to tune into live in-person sessions and/or watch captured in-person sessions on-demand in addition to having a variety of virtual-only sessions to attend.

Patient and Caregiver Diversity in FDA Patient Engagement Activities and CBER-Regulated Therapeutics: A Review of the Literature

Speaker(s)

Melgar Castillo A1, Rosenberg S2, Abdelwadoud M3, Jackler K4, Lee C4, Araojo R4, Edwards HA1, Oehrlein E5, Perfetto EM1, Mullins CD6, Mattingly TJ1
1University of Maryland School of Pharmacy, Baltimore, MD, USA, 2U.S. FDA, Washington, DC, USA, 3University of Maryland Baltimore, Baltimore, MD, USA, 4U.S. FDA, White Oak, MD, USA, 5Applied Patient Experience, LLC, Washington, DC, USA, 6University of Maryland, School of Pharmacy, Baltimore, MD, USA

This review of literature is aim one of a multipronged pilot project to understand what is known about current research and efforts related to increasing diverse patient engagement in drug development and factors that contribute to variances in knowledge of- and participation in- patient engagement activities relevant to U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) regulated products for food allergies.

A two-fold approach was used to conduct this review: (1) a scoping systematic literature, and (2) a review of grey literature. Research abstracts were screened and reviewed following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines for articles published between years 2012-2021. All abstracts were screened by two trained researchers and reviewed by a third using predefined inclusion criteria. Grey literature was information identified from food allergy organization websites and screened for inclusion by two trained researchers following prespecified criteria. A Microsoft excel® tracking tool was built to organize extracted data. Finally, a framework developed by the National Health Council (NHC) was adapted and used to synthesize the extracted data for both approaches.

Seven out of 1,370 research abstracts were included for full text data analysis. In most (86%), patients and caregivers were solely study participants, compared to one study (14%) in which they were actively involved in informing the research process. Sixteen organization websites were identified for screening—seven of which were included for analysis. 71.4% (5/7 organizations) reported engagement opportunities for patients/caregivers but did not explicitly share how diverse populations were encouraged to engage.

The importance of diverse patient engagement in food allergy therapeutic development has been stressed by both patient organizations and in research. However, further exploration is needed in how to meaningfully engage diverse groups of patients and caregivers impacted by food allergies to help inform regulatory decision-making

Code

PCR39

Topic

Patient-Centered Research

Topic Subcategory

Patient Engagement

Disease

Respiratory-Related Disorders